Two cases of importation of New Delhi metallo-β-lactamase 1 into Northern Ireland

Ulster Medical Journal

Volumn 81, Issue 3, 2012, Pages 154-155

  Nagar, Aaron ^a   Yew, Peter ^a   Ong, Grace ^a   Black, Claire ^b   Fogarty, Brendan ^b   Christie, Sharon ^b   Hedderwick, Sarah ^a   Kealey, David ^a   Livermore, David M ^c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE; BETA-LACTAMASE NDM-1;

BIOSYNTHESIS; CASE REPORT; CHILD; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MALE; MIDDLE AGED; NORTHERN IRELAND; POLYMERASE CHAIN REACTION;

EID: 84868329148     PISSN: 00416193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007;20(3): 440-58.
2. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9): 597-602
3. Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection and the Health Protection Agency. Advice on Carbapenemase Producers: Recognition, infection control and treatment. London: Health Protection Agency; 2011 [cited 2011 Jul 12]. Available from: http://www.hpa.org.uk/web/HPAwebFile/ HPAweb_C/1294740725984.